In the BioHarmony Drug Report Database

"Preview" Icon

Chlorprothixene

Taractan (chlorprothixene) is a small molecule pharmaceutical. Chlorprothixene was first approved as Taractan on 1982-01-01. It is used to treat paranoid schizophrenia and psychotic disorders in the USA.

 

Trade Name

 

Taractan
 

Common Name

 

chlorprothixene
 

ChEMBL ID

 

CHEMBL908
 

Indication

 

paranoid schizophrenia, psychotic disorders
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Chlorprothixene structure rendering